Healthcare Finance News January 2, 2026
Model enables state Medicaid agencies and Medicare Part D to cover GLP-1 drugs.
The Centers for Medicare & Medicaid Services has announced a voluntary test of a model to give Medicare Part D plans and state Medicaid agencies the ability to cover GLP-1 medications used for weight management and metabolic health improvement.
The Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model builds on emerging evidence that combining access to GLP-1 medications with access to evidence-based lifestyle achieves better long-term health outcomes, CMS said.
“The model represents a major step toward potential expanded access and affordability for millions of Americans,” CMS said.
Participation is voluntary for manufacturers, states and plans. Additional information is expected early this...
Today's Sponsors
Today's Sponsor